Research site
New Bedford, Massachusetts 02740
4 studies enrolling now · 14 studies all time
What they study most
Asthma, Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease and Hypertension, Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Heart Failure, Migraine, Migraine Disorders, Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Rheumatoid Arthritis, Type 2 Diabetes Mellitus
Studies at this site
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin — Recruiting now
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin — Recruiting now
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Recruiting now
- A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis — Recruiting now
- A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. — Running, not enrolling
- A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure — Completed
- Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma — Completed
- Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA — Completed
- A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease — Completed
- Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention — Completed
- A Multicenter Assessment of ALD403 in Chronic Migraine — Completed
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes — Completed
- Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis — Completed
- Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1) — Stopped early